You just read:

Jennerex Presents Final Data From JX-594 Randomized Phase 2 Clinical Trial Showing Statistically Significant Survival Benefit in Patients With Advanced Liver Cancer

News provided by

Jennerex, Inc.

Nov 05, 2011, 09:00 ET